Ivermectin treatment in humans for reducing malaria transmission

Author:

de Souza Dziedzom K1,Thomas Rebecca2,Bradley John3,Leyrat Clemence4,Boakye Daniel A1,Okebe Joseph5

Affiliation:

1. Noguchi Memorial Institute for Medical Research, College of Health Sciences; University of Ghana; Accra Ghana

2. Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK

3. MRC International Statistics and Epidemiology Group; London School of Hygiene & Tropical Medicine; London UK

4. Medical Statistics Department; London School of Hygiene & Tropical Medicine; London UK

5. Department of International Public Health; Liverpool School of Tropical Medicine; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference86 articles.

1. Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial;Foy;Lancet,2019

2. Foy BD Alout H Seaman JA Rao S Magalhaes T Wade M RIMDAMAL I de-identified data  Data on file (as supplied 10 March 2020) 

3. Analysis of the RIMDAMAL trial - Authors' reply;Foy;Lancet,2019

4. Repeat ivermectin mass drug administrations for control of malaria: a pilot safety and efficacy study clinicaltrials.gov/show/nct02509481

5. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments;Meyers;Malaria Journal,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3